Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The medicine is being marketed under the brand name Lirafit after receiving permission from the medicine Controller General of India (DCGI)
A retrospective cohort of 9,386 patients with lupus and type 2 diabetes found that GLP-1 receptor agonist exposure was associated with lower one-year relative risk of lupus nephritis, RR 0.59 with a 95% confidence interval of 0.40 to 0.86
GLP-1 plays a significant role in blood sugar regulation, insulin production, and appetite suppression
In: American Journal of Physiology Endocrinology And Metabolism
US$ 26.01
US$ 27.28
US$ 26.02
US$ 23.16
US$ 26.17
)
US$ 23.72
